Cogensus AI, Inc.

Cogensus AI, Inc. is a US-based company that specializes in leveraging generative AI and machine learning to enhance cognitive health for older adults through a comprehensive digital health platform. Founded in 2024 in Sheridan, US, Cogensus AI, Inc. operates a digital health platform aimed at improving cognitive health among older adults.

The company has completed 1 deal, with the most recent deal occurring on June 4, 2026, when Caduceus Capital Partners invested in the firm. The financial terms of the transaction were not disclosed, and the investment is intended to support the company’s growth and expansion efforts. Cogensus offers a proprietary digital health platform designed to enhance cognitive health among older adults through the use of generative AI and machine learning. The platform aims to reduce social isolation and foster meaningful family connections by employing algorithms that create personalized interactions and preserve memories for users.

The end users of this technology include older adults, healthcare providers, and families, providing them with tools to monitor cognitive health and engage in proactive care. Cogensus’s products are specifically marketed to various geographical regions, focusing on the United States and several countries in Europe and Asia where aging demographics are prominent. Cogensus generates revenue primarily through subscription-based models, enabling continuous access to its digital health platform for both individual users and institutional clients such as healthcare providers and senior living communities. The company has established partnerships that further facilitate its revenue stream, particularly through collaborations with entities like Caduceus, enhancing the monitoring capabilities of cognitive health.

These partnerships and subscriptions are structured to provide clients with tiered access to advanced platform features, which may include personalized cognitive assessments and family engagement tools. Pricing models are determined based on the level of service and features accessed, aligning with the needs of healthcare institutions and individual users seeking cognitive health support. Cogensus AI, Inc. plans to utilize the recent investment from Caduceus Capital Partners to support its continued growth and expansion.

The company is exploring the introduction of new products designed to enhance the cognitive health platform, although specific release dates have not been mentioned. Additionally, Cogensus aims to expand its market presence by targeting new geographical regions, particularly in Europe and Asia, to better serve aging populations by 2028.